<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Oxid Med Cell Longev</journal-id><journal-id journal-id-type="iso-abbrev">Oxid Med Cell Longev</journal-id><journal-id journal-id-type="publisher-id">OMCL</journal-id><journal-title-group><journal-title>Oxidative Medicine and Cellular Longevity</journal-title></journal-title-group><issn pub-type="ppub">1942-0900</issn><issn pub-type="epub">1942-0994</issn><publisher><publisher-name>Hindawi</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">31396301</article-id><article-id pub-id-type="pmc">6664692</article-id><article-id pub-id-type="doi">10.1155/2019/5868935</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title>Antioxidant Effects of Oral Ang-(1-7) Restore Insulin Pathway and RAS Components Ameliorating Cardiometabolic Disturbances in Rats</article-title></title-group><contrib-group><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-2834-8864</contrib-id><name><surname>Figueiredo</surname><given-names>Vivian Paulino</given-names></name><xref ref-type="aff" rid="I1">
<sup>1</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Barbosa</surname><given-names>Maria Andrea</given-names></name><xref ref-type="aff" rid="I1">
<sup>1</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>de Castro</surname><given-names>Uberdan Guilherme Mendes</given-names></name><xref ref-type="aff" rid="I1">
<sup>1</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Zacarias</surname><given-names>Aline Cruz</given-names></name><xref ref-type="aff" rid="I1">
<sup>1</sup>
</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-0804-5196</contrib-id><name><surname>Bezerra</surname><given-names>Frank Silva</given-names></name><xref ref-type="aff" rid="I1">
<sup>1</sup>
</xref><xref ref-type="aff" rid="I2">
<sup>2</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>de S&#x000e1;</surname><given-names>Renata Guerra</given-names></name><xref ref-type="aff" rid="I1">
<sup>1</sup>
</xref><xref ref-type="aff" rid="I2">
<sup>2</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>de Lima</surname><given-names>Wanderson Geraldo</given-names></name><xref ref-type="aff" rid="I1">
<sup>1</sup>
</xref><xref ref-type="aff" rid="I2">
<sup>2</sup>
</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0001-8738-5852</contrib-id><name><surname>dos Santos</surname><given-names>Robson Augusto Souza</given-names></name><xref ref-type="aff" rid="I3">
<sup>3</sup>
</xref></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0001-5543-2140</contrib-id><name><surname>Alzamora</surname><given-names>Andr&#x000e9;ia Carvalho</given-names></name><email>andreiaalzamora@uol.com.br</email><xref ref-type="aff" rid="I1">
<sup>1</sup>
</xref><xref ref-type="aff" rid="I2">
<sup>2</sup>
</xref></contrib></contrib-group><aff id="I1">
<sup>1</sup>NUPEP, Universidade Federal de Ouro Preto, Ouro Preto, MG, Brazil</aff><aff id="I2">
<sup>2</sup>Departamento de Ci&#x000ea;ncias Biol&#x000f3;gicas, Instituto de Ci&#x000ea;ncias Exatas e Biol&#x000f3;gicas, Brazil</aff><aff id="I3">
<sup>3</sup>Departamento de Fisiologia e Biof&#x000ed;sica, Universidade Federal de Minas Gerais, Belo Horizonte, MG, Brazil</aff><author-notes><fn fn-type="other"><p>Academic Editor: Nadja Schroder</p></fn></author-notes><pub-date pub-type="collection"><year>2019</year></pub-date><pub-date pub-type="epub"><day>14</day><month>7</month><year>2019</year></pub-date><volume>2019</volume><elocation-id>5868935</elocation-id><history><date date-type="received"><day>15</day><month>4</month><year>2019</year></date><date date-type="rev-recd"><day>2</day><month>6</month><year>2019</year></date><date date-type="accepted"><day>10</day><month>6</month><year>2019</year></date></history><permissions><copyright-statement>Copyright &#x000a9; 2019 Vivian Paulino Figueiredo et al.</copyright-statement><copyright-year>2019</copyright-year><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><abstract><p>In prevention studies of metabolic syndrome (MetS), Ang-(1-7) has shown to improve the insulin signaling. We evaluated the HP<italic>&#x003b2;</italic>CD/Ang-(1-7) treatment on lipid metabolism, renin-angiotensin system (RAS) components, oxidative stress, and insulin pathway in the liver and gastrocnemius muscle and hepatic steatosis in rats with established MetS. After 7 weeks of high-fat (FAT) or control (CT) diets, rats were treated with cyclodextrin (HP<italic>&#x003b2;</italic>CD) or HP<italic>&#x003b2;</italic>CD/Ang-(1-7) in the last 6 weeks. FAT-HP<italic>&#x003b2;</italic>CD/empty rats showed increased adiposity index and body mass, gene expression of ACE/ANG II/AT1R axis, and oxidative stress. These results were accompanied by imbalances in the insulin pathway, worsening of liver function, hyperglycemia, and dyslipidemia. Oral HP<italic>&#x003b2;</italic>CD/Ang-(1-7) treatment decreased <italic>ACE</italic> and <italic>AT1R</italic>, increased <italic>ACE2</italic> gene expression in the liver, and restored thiobarbituric acid reactive substances (TBARS), catalase (CAT), superoxide dismutase (SOD), insulin receptor substrate (<italic>Irs-1</italic>), glucose transporter type 4 (<italic>GLUT4</italic>), and serine/threonine kinase 2 (<italic>AKT-2</italic>) gene expression in the liver and gastrocnemius muscle improving hepatic function, cholesterol levels, and hyperglycemia in MetS rats. Overall, HP<italic>&#x003b2;</italic>CD/Ang-(1-7) treatment restored the RAS components, oxidative stress, and insulin signaling in the liver and gastrocnemius muscle contributing to the establishment of blood glucose and lipid homeostasis in MetS rats.</p></abstract><funding-group><award-group><funding-source>Coordena&#x000e7;&#x000e3;o de Aperfei&#x000e7;oamento de Pessoal de N&#x000ed;vel Superior</funding-source></award-group><award-group><funding-source>Conselho Nacional de Desenvolvimento Cient&#x000ed;fico e Tecnol&#x000f3;gico</funding-source></award-group><award-group><funding-source>Funda&#x000e7;&#x000e3;o de Amparo &#x000e0; Pesquisa do Estado de Minas Gerais</funding-source></award-group><award-group><funding-source>Universidade Federal de Ouro Preto</funding-source></award-group></funding-group></article-meta></front><body><sec id="sec1"><title>1. Introduction</title><p>The angiotensin-converting enzyme (ACE)2/angiotensin-(1-7)/Mas receptor axis belongs to the renin-angiotensin system (RAS) and has antiproliferative, antioxidant, and anti-inflammatory properties. This axis induces beneficial effects in hypertension, glucose intolerance, and insulin resistance (IR), and it acts in a counter-regulatory way to another important RAS axis, ACE/Ang II/AT1 receptor [<xref rid="B1" ref-type="bibr">1</xref>]. Imbalances in the actions of RAS components can trigger many pathological processes and disturbances in the metabolic functions of the liver and muscle, such as those observed in the metabolic syndrome (MetS) and diabetes mellitus type 2 (DM2) [<xref rid="B2" ref-type="bibr">2</xref>&#x02013;<xref rid="B4" ref-type="bibr">4</xref>]. Previous studies have shown the correlation between increased oxidative stress and IR [<xref rid="B5" ref-type="bibr">5</xref>, <xref rid="B6" ref-type="bibr">6</xref>] and hyperactivity of the ACE/Ang II/AT1 axis [<xref rid="B7" ref-type="bibr">7</xref>, <xref rid="B8" ref-type="bibr">8</xref>]. Increased oxidative stress impairs glucose uptake in the muscle and in the liver, decreasing insulin secretion of pancreatic <italic>&#x003b2;</italic> cells in DM2 and MetS states [<xref rid="B5" ref-type="bibr">5</xref>, <xref rid="B6" ref-type="bibr">6</xref>, <xref rid="B9" ref-type="bibr">9</xref>].</p><p>A high-fat (FAT) diet has been reported as risk factor RAS components for the development of DM2 and MetS [<xref rid="B10" ref-type="bibr">10</xref>, <xref rid="B11" ref-type="bibr">11</xref>]. Ang-(1-7) prevents the damage in the insulin pathway in the gastrocnemius muscle and liver in the development of MetS [<xref rid="B10" ref-type="bibr">10</xref>, <xref rid="B12" ref-type="bibr">12</xref>]. However, there are no studies on the effect of an oral Ang-(1-7) treatment on the established MetS correlating oxidative stress, insulin signaling pathway, and RAS components balance. Thus, we evaluated whether Ang-(1-7) included in the oligosaccharide hydroxypropyl-<italic>&#x003b2;</italic>-cyclodextrin (HP<italic>&#x003b2;</italic>CD) can be used as treatment in MetS already established in rats fed with FAT diet on lipid homeostasis, RAS axis components, oxidative stress, insulin pathway, and liver function. HP<italic>&#x003b2;</italic>CD has been reported to protect the Ang-(1-7) peptide during passage through the gastrointestinal tract after oral administration [<xref rid="B13" ref-type="bibr">13</xref>, <xref rid="B14" ref-type="bibr">14</xref>].</p></sec><sec id="sec2"><title>2. Materials and Methods</title><sec id="sec2.1"><title>2.1. Ethical Approval</title><p>All procedures were performed in accordance with the Guidelines for Ethics in Care of Experimental Animals. The project was approved by the animal ethics committee of the Federal University of Ouro Preto protocol 2011/31.</p></sec><sec id="sec2.2"><title>2.2. Study Design</title><p>Four-week-old Fisher rats, weighing 49 &#x000b1; 7&#x000a0;g (<italic>n</italic> = 28), from the animal facility of UFOP remained in individual cages (22 &#x000b1; 2&#x000b0;C) with a light-dark cycle from 12&#x02009;h to 12&#x02009;h and free access to water and diets. After weaning, the animals were fed with control diet (AIN-93M, CT: carbohydrate 75,82%; fat 9,46%; protein 14,72%; kcal/g 3,8) or high-fat diet [FAT: carbohydrate 15,92%; fat 68,48%-37% from lard; protein 15,60%; kcal/g 5,2] for 13 weeks, and food intake was evaluated weekly. In the seventh week of diets, MetS symptoms were analyzed such as body mass, fasting (12&#x02009;h) glucose using commercial kits (Labtest, Lagoa Santa, MG, Brazil), and mean arterial pressure (MAP) and heart rate (HR) by digital tail plethysmography (Panlab, LE5001). After seven weeks of the diets, orally by gavage, the treatment with HP<italic>&#x003b2;</italic>CD/Ang-(1-7) (40&#x000a0;<italic>&#x003bc;</italic>g/kg/day) or HP<italic>&#x003b2;</italic>CD/empty [HP<italic>&#x003b2;</italic>CD without the inclusion of Ang-(1-7)] was started for six weeks. At the end of the 13 weeks, the rats were fasted for 12&#x02009;h and decapitated [<xref rid="B6" ref-type="bibr">6</xref>, <xref rid="B11" ref-type="bibr">11</xref>]. Blood samples were collected and centrifuged (8000g, 4&#x000b0;C, 6&#x02009;min). The serum was collected and the liver, fat deposits (retroperitoneal, epididymal, and inguinal), and gastrocnemius muscle were removed, weighed (g/100&#x02009;g rat mass), placed in liquid nitrogen, and stored at -80&#x000b0;C for qRT-PCR and oxidative stress evaluations. The experimental groups were as follows: (1) CT-HP<italic>&#x003b2;</italic>CD/empty (<italic>n</italic> = 7): rats fed with CT diet and treated with empty HP<italic>&#x003b2;</italic>CD during the last six weeks of diet; (2) CT-HP<italic>&#x003b2;</italic>CD/Ang-(1-7) (<italic>n</italic> = 7): rats fed with CT diet and treated with HP<italic>&#x003b2;</italic>CD/Ang-(1-7) during the last six weeks of diet; (3) FAT-HP<italic>&#x003b2;</italic>CD/empty (<italic>n</italic> = 7): rats fed with FAT diet and treated with empty HP<italic>&#x003b2;</italic>CD during the last six weeks of diet; and (4) FAT-HP<italic>&#x003b2;</italic>CD/Ang-(1-7) (<italic>n</italic> = 7): rats fed with FAT diet and treated with HP<italic>&#x003b2;</italic>CD/Ang-(1-7) during the last six weeks of diet.</p></sec><sec id="sec2.3"><title>2.3. Adiposity Index</title><p>Adiposity index was measured by the formula [inguinal fat&#x02009;+&#x02009;epididymal fat&#x02009;+&#x02009;retroperitoneal fat absolute] [<xref rid="B15" ref-type="bibr">15</xref>].</p></sec><sec id="sec2.4"><title>2.4. Fasting Glucose and Serum Lipid Profile Analysis</title><p>At the end of the experiment, after euthanasia by instant decapitation of animals fasted overnight, blood samples (2 to 3&#x02009;mL) were collected and centrifuged (8000g, 4&#x000b0;C, 6&#x02009;min) to separate the serum for determination of fasting glucose, total cholesterol, LDL, high-density lipoprotein (HDL), alanine aminotransferase (ALT), and aspartate aminotransferase (AST). The serum was aliquoted and stored at (&#x02212;80&#x000b0;C) to conduct the biochemical analyses. The analyses were performed using individual commercial kits (Labtest, Lagoa Santa, MG, Brazil) according to the instructions provided by the manufacturer. Analyses were performed in the Pilot Laboratory of Clinical Analyses (LAPAC/UFOP).</p></sec><sec id="sec2.5"><title>2.5. Activity of Superoxide Dismutase and Catalase</title><p>Frozen liver and gastrocnemius muscle samples (100&#x02009;mg) were homogenized in phosphate buffer (pH&#x02009;7.4) and centrifuged at 12.000xg for 10&#x02009;min at 4&#x000b0;C. Elisa reader at 570&#x02009;nm was used to determine SOD activity as previously described [<xref rid="B6" ref-type="bibr">6</xref>, <xref rid="B16" ref-type="bibr">16</xref>]. CAT activity was measured by the rate of decrease of the hydrogen peroxide (H<sub>2</sub>O<sub>2</sub>) at 240&#x02009;nm. The total protein content in samples of organ homogenates was determined by using the Bradford method [<xref rid="B17" ref-type="bibr">17</xref>]. All results were expressed as activity per protein milligram.</p></sec><sec id="sec2.6"><title>2.6. Substance Reactive to Thiobarbituric Acid</title><p>The formation of TBARS during an acid warming reaction was used for lipid peroxidation index [<xref rid="B6" ref-type="bibr">6</xref>]. Frozen samples of the liver and gastrocnemius muscle (100&#x02009;mg) were homogenized in KPE (potassium phosphate-EDTA) buffer (pH&#x02009;7.4) and centrifuged (10.000xg, 10&#x02009;min at 4&#x000b0;C). The supernatant was collected and mixed with 1&#x02009;mL of 10% trichloroacetic acid and 1&#x02009;mL of 0.67% thiobarbituric acid. After this, it was heated in a boiling water bath for 30&#x02009;min. TBARS were determined from the absorbance at 532&#x02009;nm. Data series were expressed in nmol/mg protein.</p></sec><sec id="sec2.7"><title>2.7. Analysis of Gene Expression</title><p>RNA extraction and real-time reverse transcription polymerase chain reaction (qRT-PCR) were performed in the hepatic and muscular tissues as previously described [<xref rid="B6" ref-type="bibr">6</xref>]. The analyses were performed by relative method of quantification of gene expression (comparative Cq, <italic>&#x00394;</italic>Cq) and expression values were normalized for the amount of the reference gene (18S rRNA) in each plate. The results were obtained from the formula given by (2-<italic>&#x00394;</italic>Cq). The primer pairs were <italic>Rn18s</italic> (5&#x02032;-GTAAGTGCGGGTCATAAG-3&#x02032; and 5&#x02032;-CCATCCAATCGGTAGTAGC-3&#x02032;), <italic>Inrs</italic> (5&#x02032;-CCTTGGATCGTTCCTCTCAC-3&#x02032; and 5&#x02032;-GGTCCGTTTGATGCTCAGAG-3&#x02032;), <italic>Irs-1</italic> (5&#x02032;-TGAGAGCGGTGGTGGTAAGC-3&#x02032; and 5&#x02032;-GGGCTGCTGGTGTTGGAATC-3&#x02032;), <italic>Irs-2</italic> (5&#x02032;-GCAGGACTTTCCCAGTGAACG-3&#x02032; and 5&#x02032;-GCCACACCACATTCGCATG-3&#x02032;), <italic>Akt-2</italic> (5&#x02032;-GGAGGTCATGGAGCATCGGTTC-3&#x02032; and 5&#x02032;-GTTTGAAGGGTGGCAGGAGC-3&#x02032;), <italic>Slc2a4</italic> (<italic>Glut-4</italic>) (5&#x02032;-GGTGCCTTGGGAACACTCAAC-3&#x02032; and 5&#x02032;-TGCAGGAGAGCAGGGAGTACTG-3&#x02032;), <italic>angiotensinogen</italic> (5&#x02032;-CTGTGAAGGAGGGAGACTGC-3&#x02032; and 5&#x02032;-CAGCAAGCCCTGACCAGC-3&#x02032;), A<italic>CE2</italic> (5&#x02032;-GAGATGAAGCGGGAGATCG-3&#x02032; and 5&#x02032;-TGGAACAGAGATGCAGGGTC-3&#x02032;), <italic>Agtr1a/b</italic> (5&#x02032;-TCACTTTCCTGGATGTGCTG-3&#x02032; and 5&#x02032;-GATGGGCATGGCAGTGTC-3&#x02032;), <italic>Mas</italic> (5&#x02032;-CAATCGTGACGTTATCGGTG-3&#x02032; and 5&#x02032;-TCTCTCCACACTGAT GGCTG-3&#x02032;), and <italic>ACE</italic> (5&#x02032;-TGGCACTTGTCTGTCACTGG-3&#x02032; and 5&#x02032;-ACACCCAAAGCA ATTCTTCG-3&#x02032;).</p></sec><sec id="sec2.8"><title>2.8. Histological Analyses</title><p>Fragments of the liver were fixed in 10% formalin for 72&#x02009;h, dehydrated, cleaned, and embedded in paraffin. The paraffin blocks were sectioned at 4&#x000a0;<italic>&#x003bc;</italic>m thick and stained with hematoxylin and eosin (H&#x00026;E). The presence or absence of areas with nonalcoholic micro and macro steatoses (NAFLD) was observed by light microscopy in the hepatic tissue. Representative photomicrographs were obtained with a Leica BM5000 microscope coupled to a Leica DFC 300 FX camera in RGB mode, using a 40x magnification lens.</p></sec><sec id="sec2.9"><title>2.9. Statistical Analysis</title><p>Results are expressed as means &#x000b1; SEM. Data were analyzed for Kolmogorov-Smirnov normality and followed the standard normal distribution. After, they were evaluated by two-way ANOVA, followed by Fisher's LSD post test. Statistical analyses were performed with GraphPad Prism software (version 6.0, San Diego, USA). Statistical significance was set at <italic>p</italic> &#x0003c; 0.05.</p></sec></sec><sec id="sec3"><title>3. Results</title><sec id="sec3.1"><title>3.1. Evaluation of MetS Establishment</title><p>In the seventh week of diets, the FAT-HP<italic>&#x003b2;</italic>CD/empty rats showed symptoms of MetS such as increased fasting blood glucose, MAP, HR, and body mass, compared to CT-HP<italic>&#x003b2;</italic>CD/empty rats (<xref rid="tab1" ref-type="table">Table 1</xref>).</p></sec><sec id="sec3.2"><title>3.2. Evaluation of Nutritional, Biometric, and Biochemical Parameters</title><p>In the last six weeks of diets, FAT-HP<italic>&#x003b2;</italic>CD/empty rats displayed increased body mass, adiposity index, fasting glucose, total cholesterol, LDL, triglycerides, and ALT levels compared to CT-HP<italic>&#x003b2;</italic>CD/empty (<xref rid="tab2" ref-type="table">Table 2</xref>). However, FAT-HP<italic>&#x003b2;</italic>CD/Ang-(1-7) rats improved body mass, adiposity index, fasting glucose, total cholesterol, LDL, triglycerides, and ALT levels compared to the CT-HP<italic>&#x003b2;</italic>CD/empty rats (<xref rid="tab2" ref-type="table">Table 2</xref>). Additionally, FAT-HP<italic>&#x003b2;</italic>CD/empty and FAT-HP<italic>&#x003b2;</italic>CD/Ang-(1-7) rats presented decreased food intake but similar caloric intake compared to CT-HP<italic>&#x003b2;</italic>CD/empty. No difference was found in liver and gastrocnemius muscle, HDL, and AST levels between groups (<xref rid="tab2" ref-type="table">Table 2</xref>).</p></sec><sec id="sec3.3"><title>3.3. Evaluation of Oxidative Stress</title><p>FAT-HP<italic>&#x003b2;</italic>CD/empty rats presented increased TBARS concentration and decreased CAT activity in the liver and gastrocnemius muscle compared to CT-HP<italic>&#x003b2;</italic>CD/empty rats (<xref ref-type="fig" rid="fig1">Figure 1(a)</xref>&#x02013;(d)). However, FAT-HP<italic>&#x003b2;</italic>CD/Ang-(1-7) rats decreased TBARS concentration and increased CAT activity in the liver and gastrocnemius muscle compared to FAT-HP<italic>&#x003b2;</italic>CD/empty animals (<xref ref-type="fig" rid="fig1">Figure 1(a)</xref>&#x02013;(d)). The concentrations of TBARS and CAT activity in FAT-HP<italic>&#x003b2;</italic>CD/Ang-(1-7) rats became similar to the CT-HP<italic>&#x003b2;</italic>CD/empty rats. In addition, only FAT-HP<italic>&#x003b2;</italic>CD/Ang-(1-7) rats showed increased liver SOD activity compared to FAT-HP<italic>&#x003b2;</italic>CD/empty rats (<xref ref-type="fig" rid="fig1">Figure 1(e)</xref>). No difference was observed in SOD activity in the gastrocnemius muscle (<xref ref-type="fig" rid="fig1">Figure 1(f)</xref>).</p></sec><sec id="sec3.4"><title>3.4. mRNA Expression of the RAS Components and the Insulin Signaling Pathway</title><p>FAT-HP<italic>&#x003b2;</italic>CD/empty rats showed increased <italic>angiotensinogen</italic>, <italic>ACE</italic>, <italic>AT1R</italic>, and <italic>Masr</italic> mRNA gene expression compared to CT-HP<italic>&#x003b2;</italic>CD/empty rats (Figures <xref ref-type="fig" rid="fig2">2(a)</xref>&#x02013;<xref ref-type="fig" rid="fig2">2(c)</xref> and <xref ref-type="fig" rid="fig2">2(e)</xref>). However, FAT-HP<italic>&#x003b2;</italic>CD/Ang-(1-7) rats decreased <italic>ACE</italic> and <italic>AT1R</italic> increasing <italic>ACE2</italic> gene expression compared to FAT-HP<italic>&#x003b2;</italic>CD/empty rats (Figures <xref ref-type="fig" rid="fig2">2(b)</xref>&#x02013;<xref ref-type="fig" rid="fig2">2(d)</xref>).</p><p>FAT-HP<italic>&#x003b2;</italic>CD/empty rats presented lower gene expression of the <italic>Irs-1</italic> and <italic>Akt-2</italic> components of the intracellular insulin pathway in the liver and gastrocnemius muscle compared to CT-HP<italic>&#x003b2;</italic>CD/empty rats (<xref ref-type="fig" rid="fig3">Figure 3(a)</xref>&#x02013;(d)). In addition, FAT-HP<italic>&#x003b2;</italic>CD/empty group presented lower <italic>Glut-4</italic> gene expression in the gastrocnemius muscle compared to CT-HP<italic>&#x003b2;</italic>CD/empty rats (<xref ref-type="fig" rid="fig3">Figure 3(f)</xref>). FAT-HP<italic>&#x003b2;</italic>CD/Ang-(1-7) rats presented increased <italic>Glut-4</italic> gene expression in the liver compared to FAT-HP<italic>&#x003b2;</italic>CD/empty group (<xref ref-type="fig" rid="fig3">Figure 3(e)</xref>). In addition, in the FAT-HP<italic>&#x003b2;</italic>CD/Ang-(1-7) rats, the mRNA expression of <italic>Glut-4</italic> became similar to CT-HP<italic>&#x003b2;</italic>CD/empty rats in the liver and gastrocnemius muscle (Figures <xref ref-type="fig" rid="fig3">3(e)</xref> and (f)). No differences in mRNA expression of <italic>Inrs</italic> and <italic>Irs-2</italic> were observed among all groups of rats in the liver and gastrocnemius muscle (data not shown).</p></sec><sec id="sec3.5"><title>3.5. Analysis of Hepatic Steatosis</title><p>Liver histology revealed that FAT-HP<italic>&#x003b2;</italic>CD/empty rats presented macrovesicular steatosis with 50% of hepatocytes with mild grade, whereas FAT-HP<italic>&#x003b2;</italic>CD/Ang-(1-7) animals did not present macrovesicular steatosis (Figures <xref ref-type="fig" rid="fig4">4(a)</xref>&#x02013;<xref ref-type="fig" rid="fig4">4(e)</xref>). In relation to microvesicular steatosis, FAT-HP<italic>&#x003b2;</italic>CD/empty animals presented 50% of the hepatocytes with a mild grade and 16.6% of the hepatocytes with a moderate grade, while the FAT-HP<italic>&#x003b2;</italic>CD/Ang-(1-7) group had 50% of a discrete grade and 50% absence of hepatocytes (Figures <xref ref-type="fig" rid="fig4">4(a)</xref>, <xref ref-type="fig" rid="fig4">4(d)</xref>, and <xref ref-type="fig" rid="fig4">4(f)</xref>).</p></sec></sec><sec id="sec4"><title>4. Discussion</title><p>In the present study, we showed that the treatment with oral formulation of Ang-(1-7), HP<italic>&#x003b2;</italic>CD/Ang-(1-7), in the last six weeks in rats fed with FAT diet for 13 weeks was efficient in restoring RAS components and biometric (body mass and adiposity index) and biochemical (triglycerides, LDL, total cholesterol, fasting glucose, and ALT) parameters, reducing oxidative stress, and improving the insulin signaling pathway in the liver and gastrocnemius muscle and macrovesicular liver damage.</p><p>In previous studies [<xref rid="B6" ref-type="bibr">6</xref>, <xref rid="B11" ref-type="bibr">11</xref>, <xref rid="B15" ref-type="bibr">15</xref>] using the same diet protocol, we showed that rats fed with FAT diet for 7 weeks had disorders related to human MetS, such as increased fat deposits (epididymal, retroperitoneal, and inguinal), MAP, HR, fasting glucose, ALT, and total cholesterol levels. In the present study on the seventh week, the FAT-HP<italic>&#x003b2;</italic>CD/empty rats already had disorders characteristic of MetS such as elevated fasting glucose, body mass, MAP, and HR, so the present study refers to treatment and not prevention to the development of MetS.</p><p>This present study showed that oral Ang-(1-7) treatment in established MetS rats normalized body mass, adiposity index, LDL cholesterol, and triglycerides compared to untreated MetS rats. These data are in agreement with studies of prevention in transgenic rat model of inducible DM2 (Tet29) [<xref rid="B18" ref-type="bibr">18</xref>] insulin resistance and mice (FVB/N) fed with FAT diet [<xref rid="B4" ref-type="bibr">4</xref>] that oral Ang-(1-7) induced reductions on fat deposits, total cholesterol, ALT levels [<xref rid="B4" ref-type="bibr">4</xref>], and glucose levels [<xref rid="B18" ref-type="bibr">18</xref>].</p><p>Studies have shown that the ACE/Ang II/AT1 receptor axis is involved with oxidative stress and IR in the DM2 and MetS states [<xref rid="B7" ref-type="bibr">7</xref>, <xref rid="B8" ref-type="bibr">8</xref>, <xref rid="B18" ref-type="bibr">18</xref>&#x02013;<xref rid="B20" ref-type="bibr">20</xref>]. The unbalance between reactive oxygen species (ROS) and detoxification by antioxidant enzymes can affect intracellular signaling pathways being an important mechanism for metabolic diseases [<xref rid="B5" ref-type="bibr">5</xref>, <xref rid="B21" ref-type="bibr">21</xref>]. Oxidative damage is related to IR in the liver and gastrocnemius muscle [<xref rid="B21" ref-type="bibr">21</xref>, <xref rid="B22" ref-type="bibr">22</xref>]. In addition, the hepatic CAT enzyme activity that is responsible for the part of H<sub>2</sub>O<sub>2</sub> elimination is reduced in the liver in situations of MetS in the rat model [<xref rid="B6" ref-type="bibr">6</xref>, <xref rid="B21" ref-type="bibr">21</xref>]. It has already been established in the literature that Ang II participates in these cardiometabolic diseases due to its pro-oxidant actions, while Ang-(1-7) presents regulatory actions against Ang II actions [<xref rid="B1" ref-type="bibr">1</xref>, <xref rid="B20" ref-type="bibr">20</xref>, <xref rid="B23" ref-type="bibr">23</xref>, <xref rid="B24" ref-type="bibr">24</xref>]. In fact, Cao et al.'s study [<xref rid="B12" ref-type="bibr">12</xref>] showed in knockout mice for ACE2 (ACE2 KO) presented IR and elevated levels of ROS in the liver. Additionally, in the prevention study in FVB/N mice fed with FAT diet [<xref rid="B19" ref-type="bibr">19</xref>] or in high-fructose obese mouse model [<xref rid="B25" ref-type="bibr">25</xref>], Ang-(1-7) improved superoxide production in epididymal fat and improved lipid metabolism associated with increased <italic>Ace2</italic> and decreased <italic>Ace</italic> expression in the liver [<xref rid="B25" ref-type="bibr">25</xref>]. The present study is in agreement with these studies, where FAT-HP<italic>&#x003b2;</italic>CD/empty rats showed increased expression of angiotensinogen, <italic>ACE</italic>, and <italic>AT1R</italic> in the liver, increased TBARS concentration, and decreased CAT activity in the liver and in the gastrocnemius muscle. The oral treatment with Ang-(1-7) was effective in decreasing hepatic <italic>ACE</italic> and <italic>AT1R</italic>, increasing <italic>ACE2</italic> gene expression, and restoring CAT activity and TBARS concentration in FAT-HP<italic>&#x003b2;</italic>CD/Ang-(1-7) rats. In addition, our data showed that Ang-(1-7) treatment increased the SOD activity in the liver, thus increasing the ability to dismutase the superoxide anion to H<sub>2</sub>O<sub>2</sub> and reducing the oxidation products by reducing TBARS concentration in FAT-HP<italic>&#x003b2;</italic>CD/Ang-(1-7) rats.</p><p>In prevention studies, using oral administration of HP<italic>&#x003b2;</italic>CD/Ang-(1-7) in transgenic DM2 mice [<xref rid="B18" ref-type="bibr">18</xref>] and FVB/N mice fed with FAT diet [<xref rid="B4" ref-type="bibr">4</xref>] showed, in epididymal adipose tissue, normalization of glucose tolerance, insulin sensitivity, and fasting blood glucose [<xref rid="B4" ref-type="bibr">4</xref>, <xref rid="B18" ref-type="bibr">18</xref>]. Additionally, Giani et al.'s and Mu&#x000f1;oz et al.'s studies [<xref rid="B10" ref-type="bibr">10</xref>, <xref rid="B24" ref-type="bibr">24</xref>] have showed in rats fed with 10% fructose in water for six weeks and treated with Ang-(1-7) by osmotic pump in the last two weeks of diet the normalization of insulin signaling components (IR/IRS-1/PI3K/AKT) in the skeletal muscle, liver, and adipose tissue. Accordingly, the present data showed a reduction in mRNA expression of IRS-1 and AKT-2 in the liver and gastrocnemius muscle while GLUT-4 was reduced only in gastrocnemius muscle in FAT-HP<italic>&#x003b2;</italic>CD/empty rats. However, the treatment with Ang-(1-7) in the last six weeks of FAT diet became the expression of AKT-2 and GLUT-4 in the liver and in the gastrocnemius muscle and the expression of IRS-1 in the liver of FAT-HP<italic>&#x003b2;</italic>CD/Ang-(1-7) rats similar to CT-HP<italic>&#x003b2;</italic>CD/empty rats.</p><p>Oxidative stress plays an important role in decreasing insulin sensitivity in the liver. EROs are produced by many processes [<xref rid="B9" ref-type="bibr">9</xref>], and in skeletal muscle cells, the activation of NADPH oxidase induced by Ang II may worsen insulin signaling [<xref rid="B26" ref-type="bibr">26</xref>], 2006). The ACE2/Ang-(1-7)/Mas axis, that counterregulating effects of the ACE/Ang II/AT1R axis, is involved in the reduction of insulin resistance through antioxidant effects [<xref rid="B8" ref-type="bibr">8</xref>, <xref rid="B12" ref-type="bibr">12</xref>]. Cao et al. [<xref rid="B12" ref-type="bibr">12</xref>] demonstrated in HepG2 cells that Ang-(1-7) protects against oxidative stress by inhibiting the expression of NAPDH oxidase contributing to the increasing levels of ROS that can lead to the activation of N-terminal c-Jun kinases (JNKs), which can phosphorylate IRS proteins [<xref rid="B27" ref-type="bibr">27</xref>]. Cao et al. [<xref rid="B12" ref-type="bibr">12</xref>] showed that overexpression of ACE inhibited JNK phosphorylation, leading to decreased phosphorylation of the IRS-1 serine residue, which increased glucose uptake in HepG2 cells. In addition, Ang-(1-7) increases the protein expression of GLUT-4 in the skeletal muscle of ACE2 KO mice [<xref rid="B27" ref-type="bibr">27</xref>] and induces the phosphorylation of kinase that participates in the translocation of GLUT-4, PI3K-C2alpha, in human endothelial cells [<xref rid="B28" ref-type="bibr">28</xref>] in response to insulin stimulation [<xref rid="B24" ref-type="bibr">24</xref>, <xref rid="B29" ref-type="bibr">29</xref>]. Accordingly, data from the present study show that Ang-(1-7) treatment, despite not reversing the expression of all evaluated components of the insulin pathway, made the expression of IRS-1, AKT-2, and GLUT-4 in the liver and AKT-2 and GLUT-4 in the muscle similar to the levels of expression of the control rats (HP<italic>&#x003b2;</italic>CD/empty). Additionally, Williams et al. [<xref rid="B30" ref-type="bibr">30</xref>] showed that adult male C57BL/6J mice receiving a high lipid diet for 11 weeks and treated with Ang-(1-7) infused during the last 3 weeks of diet showed increased GLUT-4 in the skeletal muscle that were sufficient to improve insulin resistance and glucose uptake. All these data together suggest that the beneficial effect of Ang-(1-7) on improving the insulin signaling pathway is probably due to restoring RAS components and redox balance in the liver and gastrocnemius muscle in MetS rats.</p><p>Hepatic IR correlates with increased fat and steatosis in the liver [<xref rid="B3" ref-type="bibr">3</xref>, <xref rid="B6" ref-type="bibr">6</xref>, <xref rid="B11" ref-type="bibr">11</xref>]. In our present study, there is increased hepatic fat accumulation in FAT-HP<italic>&#x003b2;</italic>CD/empty rats which was attenuated by treatment with HP<italic>&#x003b2;</italic>CD/Ang-(1-7). These data are in accordance with the prevention study of Feltenberger et al. [<xref rid="B19" ref-type="bibr">19</xref>] in FVB/N mice fed with FAT diet in which HP<italic>&#x003b2;</italic>CD/Ang-(1-7) reduced total weight and steatosis in the liver. Our hypothesis, based on the present data, is that the composition of FAT diet increased the circulation of free fatty acids, which could be captured and undergo lipid peroxidation products by the ROS leading to a process of hepatic steatosis, probably by <italic>Ace</italic> and <italic>AT1R</italic> contribution [<xref rid="B2" ref-type="bibr">2</xref>, <xref rid="B3" ref-type="bibr">3</xref>, <xref rid="B21" ref-type="bibr">21</xref>]. Furthermore, the steatosis may be related to hepatic IR resulting from cell injury or hepatic inflammation [<xref rid="B19" ref-type="bibr">19</xref>]. In the present study, the treatment with HP<italic>&#x003b2;</italic>CD/Ang-(1-7) was effective in restoring this damage in the liver of FAT-HP<italic>&#x003b2;</italic>CD/Ang-(1-7) rats by normalizing body mass, adiposity index, LDL cholesterol, and triglycerides; decreasing <italic>ACE</italic> and <italic>AT1R</italic>; increasing <italic>Ace2</italic> gene expression; and reversing lipid peroxidation in the liver and gastrocnemius muscle.</p><p>In conclusion, our data in rats with stablished MetS-induced FAT diet for 13 weeks and orally treated with HP<italic>&#x003b2;</italic>CD/Ang-(1-7) in the last six weeks show that Ang-(1-7) was efficient in normalizing lipid metabolism, improving the insulin signaling pathway in the liver and gastrocnemius muscle, function, and macrovesicular liver damage, probably by restoring the unbalance between RAS axis and reducing oxidative stress in the liver and gastrocnemius muscle. This protective effect of Ang-(1-7) in the liver and muscle can probably contribute in reversing the hyperglycemia and dyslipidemia in MetS-induced FAT diet rats.</p></sec></body><back><ack><title>Acknowledgments</title><p>This study was supported by the Universidade Federal de Ouro Preto (UFOP), CBIOL-UFOP, NUPEB-UFOP, Funda&#x000e7;&#x000e3;o de Amparo &#x000e0; Pesquisa do Estado de Minas Gerais (FAPEMIG), Conselho Nacional de Desenvolvimento Cient&#x000ed;fico e Tecnol&#x000f3;gico (CNPq), and Coordena&#x000e7;&#x000e3;o de Aperfei&#x000e7;oamento de Pessoal de N&#x000ed;vel Superior (CAPES). Vivian Paulino Figueiredo received a UFOP fellowship (Postdoctoral) in the Programa de P&#x000f3;s-Gradua&#x000e7;&#x000e3;o em Ci&#x000ea;ncias Biol&#x000f3;gicas, UFOP.</p></ack><sec sec-type="data-availability"><title>Data Availability</title><p>The [DATA TYPE] data used to support the findings of this study are included within the article.</p></sec><sec sec-type="COI-statement"><title>Conflicts of Interest</title><p>The authors declare no conflicting financial interests.</p></sec><ref-list><ref id="B1"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Santos</surname><given-names>R. A.</given-names></name></person-group><article-title>Angiotensin-(1-7)</article-title><source><italic toggle="yes">Hypertension</italic></source><year>2014</year><volume>63</volume><issue>6</issue><fpage>1138</fpage><lpage>1147</lpage><pub-id pub-id-type="doi">10.1161/HYPERTENSIONAHA.113.01274</pub-id><pub-id pub-id-type="other">2-s2.0-84902291577</pub-id><pub-id pub-id-type="pmid">24664288</pub-id></element-citation></ref><ref id="B2"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Abel</surname><given-names>E. D.</given-names></name><name><surname>Peroni</surname><given-names>O.</given-names></name><name><surname>Kim</surname><given-names>J. K.</given-names></name><etal/></person-group><article-title>Adipose-selective targeting of the GLUT4 gene impairs insulin action in muscle and liver</article-title><source><italic toggle="yes">Nature</italic></source><year>2001</year><volume>409</volume><issue>6821</issue><fpage>729</fpage><lpage>733</lpage><pub-id pub-id-type="doi">10.1038/35055575</pub-id><pub-id pub-id-type="other">2-s2.0-0035825643</pub-id><pub-id pub-id-type="pmid">11217863</pub-id></element-citation></ref><ref id="B3"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Asrih</surname><given-names>M.</given-names></name><name><surname>Jornayvaz</surname><given-names>F. R.</given-names></name></person-group><article-title>Metabolic syndrome and nonalcoholic fatty liver disease: is insulin resistance the link?</article-title><source><italic toggle="yes">Molecular and Cellular Endocrinology</italic></source><year>2015</year><volume>418</volume><issue>Part 1</issue><fpage>55</fpage><lpage>65</lpage><pub-id pub-id-type="doi">10.1016/j.mce.2015.02.018</pub-id><pub-id pub-id-type="other">2-s2.0-84930675030</pub-id><pub-id pub-id-type="pmid">25724480</pub-id></element-citation></ref><ref id="B4"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Oliveira Andrade</surname><given-names>J. M.</given-names></name><name><surname>Para&#x000ed;so</surname><given-names>A. F.</given-names></name><name><surname>Garcia</surname><given-names>Z. M.</given-names></name><etal/></person-group><article-title>Cross talk between angiotensin-(1-7)/Mas axis and sirtuins in adipose tissue and metabolism of high-fat feed mice</article-title><source><italic toggle="yes">Peptides</italic></source><year>2014</year><volume>55</volume><fpage>158</fpage><lpage>165</lpage><pub-id pub-id-type="doi">10.1016/j.peptides.2014.03.006</pub-id><pub-id pub-id-type="other">2-s2.0-84898482864</pub-id><pub-id pub-id-type="pmid">24642355</pub-id></element-citation></ref><ref id="B5"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Keane</surname><given-names>K. N.</given-names></name><name><surname>Cruzat</surname><given-names>V. F.</given-names></name><name><surname>Carlessi</surname><given-names>R.</given-names></name><name><surname>de Bittencourt</surname><given-names>P. I. H.</given-names></name><name><surname>Newsholme</surname><given-names>P.</given-names></name></person-group><article-title>Molecular events linking oxidative stress and inflammation to insulin resistance and <italic>&#x003b2;</italic>-cell dysfunction</article-title><source><italic toggle="yes">Oxidative Medicine and Cellular Longevity</italic></source><year>2015</year><volume>2015</volume><fpage>15</fpage><pub-id pub-id-type="publisher-id">181643</pub-id><pub-id pub-id-type="doi">10.1155/2015/181643</pub-id><pub-id pub-id-type="other">2-s2.0-84938153225</pub-id><pub-id pub-id-type="pmid">26257839</pub-id></element-citation></ref><ref id="B6"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zacarias</surname><given-names>A. C.</given-names></name><name><surname>Barbosa</surname><given-names>M. A.</given-names></name><name><surname>Guerra-S&#x000e1;</surname><given-names>R.</given-names></name><etal/></person-group><article-title>Swimming training induces liver adaptations to oxidative stress and insulin sensitivity in rats submitted to high-fat diet</article-title><source><italic toggle="yes">Redox Report</italic></source><year>2017</year><volume>22</volume><issue>6</issue><fpage>515</fpage><lpage>523</lpage><pub-id pub-id-type="doi">10.1080/13510002.2017.1315513</pub-id><pub-id pub-id-type="other">2-s2.0-85017466894</pub-id><pub-id pub-id-type="pmid">28403686</pub-id></element-citation></ref><ref id="B7"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Thorwald</surname><given-names>M.</given-names></name><name><surname>Rodriguez</surname><given-names>R.</given-names></name><name><surname>Lee</surname><given-names>A.</given-names></name><etal/></person-group><article-title>Angiotensin receptor blockade improves cardiac mitochondrial activity in response to an acute glucose load in obese insulin resistant rats</article-title><source><italic toggle="yes">Redox Biology</italic></source><year>2018</year><volume>14</volume><fpage>371</fpage><lpage>378</lpage><pub-id pub-id-type="doi">10.1016/j.redox.2017.10.005</pub-id><pub-id pub-id-type="other">2-s2.0-85031756339</pub-id><pub-id pub-id-type="pmid">29049981</pub-id></element-citation></ref><ref id="B8"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>C.</given-names></name><name><surname>Lv</surname><given-names>X. H.</given-names></name><name><surname>Li</surname><given-names>H. X.</given-names></name><etal/></person-group><article-title>Angiotensin-(1-7) suppresses oxidative stress and improves glucose uptake via Mas receptor in adipocytes</article-title><source><italic toggle="yes">Acta Diabetologica</italic></source><year>2012</year><volume>49</volume><issue>4</issue><fpage>291</fpage><lpage>299</lpage><pub-id pub-id-type="doi">10.1007/s00592-011-0348-z</pub-id><pub-id pub-id-type="other">2-s2.0-84864934564</pub-id><pub-id pub-id-type="pmid">22042130</pub-id></element-citation></ref><ref id="B9"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Furukawa</surname><given-names>S.</given-names></name><name><surname>Fujita</surname><given-names>T.</given-names></name><name><surname>Shimabukuro</surname><given-names>M.</given-names></name><etal/></person-group><article-title>Increased oxidative stress in obesity and its impact on metabolic syndrome</article-title><source><italic toggle="yes">The Journal of Clinical Investigation</italic></source><year>2004</year><volume>114</volume><issue>12</issue><fpage>1752</fpage><lpage>1761</lpage><pub-id pub-id-type="doi">10.1172/JCI21625</pub-id><pub-id pub-id-type="other">2-s2.0-85030434746</pub-id><pub-id pub-id-type="pmid">15599400</pub-id></element-citation></ref><ref id="B10"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Giani</surname><given-names>J. F.</given-names></name><name><surname>Mayer</surname><given-names>M. A.</given-names></name><name><surname>Mu&#x000f1;oz</surname><given-names>M. C.</given-names></name><etal/></person-group><article-title>Chronic infusion of angiotensin-(1-7) improves insulin resistance and hypertension induced by a high-fructose diet in rats</article-title><source><italic toggle="yes">American Journal of Physiology-Endocrinology and Metabolism</italic></source><year>2009</year><volume>296</volume><issue>2</issue><fpage>E262</fpage><lpage>E271</lpage><pub-id pub-id-type="doi">10.1152/ajpendo.90678.2008</pub-id><pub-id pub-id-type="other">2-s2.0-60849095515</pub-id><pub-id pub-id-type="pmid">19001546</pub-id></element-citation></ref><ref id="B11"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>de Castro</surname><given-names>U. G. M.</given-names></name><name><surname>dos Santos</surname><given-names>R. A. S.</given-names></name><name><surname>Silva</surname><given-names>M.</given-names></name><name><surname>de Lima</surname><given-names>W.</given-names></name><name><surname>Campagnole-Santos</surname><given-names>M.</given-names></name><name><surname>Alzamora</surname><given-names>A.</given-names></name></person-group><article-title>Age-dependent effect of high-fructose and high-fat diets on lipid metabolism and lipid accumulation in liver and kidney of rats</article-title><source><italic toggle="yes">Lipids in Health and Disease</italic></source><year>2013</year><volume>12</volume><issue>1</issue><fpage>p. 136</fpage><pub-id pub-id-type="doi">10.1186/1476-511X-12-136</pub-id><pub-id pub-id-type="other">2-s2.0-84884191795</pub-id></element-citation></ref><ref id="B12"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cao</surname><given-names>X.</given-names></name><name><surname>Yang</surname><given-names>F. Y.</given-names></name><name><surname>Xin</surname><given-names>Z.</given-names></name><name><surname>Xie</surname><given-names>R. R.</given-names></name><name><surname>Yang</surname><given-names>J. K.</given-names></name></person-group><article-title>The ACE2/Ang-(1-7)/Mas axis can inhibit hepatic insulin resistance</article-title><source><italic toggle="yes">Molecular and Cellular Endocrinology</italic></source><year>2014</year><volume>393</volume><issue>1-2</issue><fpage>30</fpage><lpage>38</lpage><pub-id pub-id-type="doi">10.1016/j.mce.2014.05.024</pub-id><pub-id pub-id-type="other">2-s2.0-84903376638</pub-id><pub-id pub-id-type="pmid">24911884</pub-id></element-citation></ref><ref id="B13"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lula</surname><given-names>I.</given-names></name><name><surname>Denadai</surname><given-names>&#x000c2;. L.</given-names></name><name><surname>Resende</surname><given-names>J. M.</given-names></name><etal/></person-group><article-title>Study of angiotensin-(1-7) vasoactive peptide and its beta-cyclodextrin inclusion complexes: complete sequence-specific NMR assignments and structural studies</article-title><source><italic toggle="yes">Peptides</italic></source><year>2007</year><volume>28</volume><issue>11</issue><fpage>2199</fpage><lpage>2210</lpage><pub-id pub-id-type="doi">10.1016/j.peptides.2007.08.011</pub-id><pub-id pub-id-type="other">2-s2.0-35349001774</pub-id><pub-id pub-id-type="pmid">17904691</pub-id></element-citation></ref><ref id="B14"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fraga-Silva</surname><given-names>R. A.</given-names></name><name><surname>Costa-Fraga</surname><given-names>F. P.</given-names></name><name><surname>Sousa</surname><given-names>F. B. D.</given-names></name><etal/></person-group><article-title>An orally active formulation of angiotensin-(1-7) produces an antithrombotic effect</article-title><source><italic toggle="yes">Clinics (S&#x000e3;o Paulo, Brazil)</italic></source><year>2011</year><volume>66</volume><issue>5</issue><fpage>837</fpage><lpage>841</lpage><pub-id pub-id-type="doi">10.1590/S1807-59322011000500021</pub-id><pub-id pub-id-type="other">2-s2.0-79960879235</pub-id><pub-id pub-id-type="pmid">21789389</pub-id></element-citation></ref><ref id="B15"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Barbosa</surname><given-names>M. A.</given-names></name><name><surname>Guerra-S&#x000e1;</surname><given-names>R.</given-names></name><name><surname>de Castro</surname><given-names>U. G. M.</given-names></name><etal/></person-group><article-title>Physical training improves thermogenesis and insulin pathway, and induces remodeling in white and brown adipose tissues</article-title><source><italic toggle="yes">Journal of Physiology and Biochemistry</italic></source><year>2018</year><volume>74</volume><issue>3</issue><fpage>441</fpage><lpage>454</lpage><pub-id pub-id-type="doi">10.1007/s13105-018-0637-x</pub-id><pub-id pub-id-type="other">2-s2.0-85047297488</pub-id><pub-id pub-id-type="pmid">29797227</pub-id></element-citation></ref><ref id="B16"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dieterich</surname><given-names>S.</given-names></name><name><surname>Bieligk</surname><given-names>U.</given-names></name><name><surname>Beulich</surname><given-names>K.</given-names></name><name><surname>Hasenfuss</surname><given-names>G.</given-names></name><name><surname>Prestle</surname><given-names>J.</given-names></name></person-group><article-title>Gene expression of antioxidative enzymes in the human heart: increased expression of catalase in the end-stage failing heart</article-title><source><italic toggle="yes">Circulation</italic></source><year>2000</year><volume>101</volume><issue>1</issue><fpage>33</fpage><lpage>39</lpage><pub-id pub-id-type="doi">10.1161/01.CIR.101.1.33</pub-id><pub-id pub-id-type="other">2-s2.0-0034602850</pub-id><pub-id pub-id-type="pmid">10618301</pub-id></element-citation></ref><ref id="B17"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bradford</surname><given-names>M. M.</given-names></name></person-group><article-title>A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding</article-title><source><italic toggle="yes">Analytical Biochemistry</italic></source><year>1976</year><volume>72</volume><issue>1-2</issue><fpage>248</fpage><lpage>254</lpage><pub-id pub-id-type="doi">10.1016/0003-2697(76)90527-3</pub-id><pub-id pub-id-type="other">2-s2.0-0017184389</pub-id><pub-id pub-id-type="pmid">942051</pub-id></element-citation></ref><ref id="B18"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Santos</surname><given-names>S. H. S.</given-names></name><name><surname>Giani</surname><given-names>J. F.</given-names></name><name><surname>Burghi</surname><given-names>V.</given-names></name><etal/></person-group><article-title>Oral administration of angiotensin-(1-7) ameliorates type 2 diabetes in rats</article-title><source><italic toggle="yes">Journal of Molecular Medicine</italic></source><year>2014</year><volume>92</volume><issue>3</issue><fpage>255</fpage><lpage>265</lpage><pub-id pub-id-type="doi">10.1007/s00109-013-1087-0</pub-id><pub-id pub-id-type="other">2-s2.0-84898472204</pub-id><pub-id pub-id-type="pmid">24162089</pub-id></element-citation></ref><ref id="B19"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Feltenberger</surname><given-names>J. D.</given-names></name><name><surname>Andrade</surname><given-names>J. M. O.</given-names></name><name><surname>Para&#x000ed;so</surname><given-names>A.</given-names></name><etal/></person-group><article-title>Oral formulation of angiotensin-(1-7) improves lipid metabolism and prevents high-fat diet-induced hepatic steatosis and inflammation in mice</article-title><source><italic toggle="yes">Hypertension</italic></source><year>2013</year><volume>62</volume><issue>2</issue><fpage>324</fpage><lpage>330</lpage><pub-id pub-id-type="doi">10.1161/HYPERTENSIONAHA.111.00919</pub-id><pub-id pub-id-type="other">2-s2.0-84880927634</pub-id><pub-id pub-id-type="pmid">23753417</pub-id></element-citation></ref><ref id="B20"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Santos</surname><given-names>S. H. S.</given-names></name><name><surname>Fernandes</surname><given-names>L. R.</given-names></name><name><surname>Mario</surname><given-names>E. G.</given-names></name><etal/></person-group><article-title>Mas deficiency in FVB/N mice produces marked changes in lipid and glycemic metabolism</article-title><source><italic toggle="yes">Diabetes</italic></source><year>2008</year><volume>57</volume><issue>2</issue><fpage>340</fpage><lpage>347</lpage><pub-id pub-id-type="doi">10.2337/db07-0953</pub-id><pub-id pub-id-type="other">2-s2.0-40749088567</pub-id><pub-id pub-id-type="pmid">18025412</pub-id></element-citation></ref><ref id="B21"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cicho&#x0017c;-Lach</surname><given-names>H.</given-names></name><name><surname>Michalak</surname><given-names>A.</given-names></name></person-group><article-title>Oxidative stress as a crucial factor in liver diseases</article-title><source><italic toggle="yes">World Journal of Gastroenterology</italic></source><year>2014</year><volume>20</volume><issue>25</issue><fpage>8082</fpage><lpage>8091</lpage><pub-id pub-id-type="doi">10.3748/wjg.v20.i25.8082</pub-id><pub-id pub-id-type="other">2-s2.0-84903971446</pub-id><pub-id pub-id-type="pmid">25009380</pub-id></element-citation></ref><ref id="B22"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Koves</surname><given-names>T. R.</given-names></name><name><surname>Ussher</surname><given-names>J. R.</given-names></name><name><surname>Noland</surname><given-names>R. C.</given-names></name><etal/></person-group><article-title>Mitochondrial overload and incomplete fatty acid oxidation contribute to skeletal muscle insulin resistance</article-title><source><italic toggle="yes">Cell Metabolism</italic></source><year>2008</year><volume>7</volume><issue>1</issue><fpage>45</fpage><lpage>56</lpage><pub-id pub-id-type="doi">10.1016/j.cmet.2007.10.013</pub-id><pub-id pub-id-type="other">2-s2.0-37449020075</pub-id><pub-id pub-id-type="pmid">18177724</pub-id></element-citation></ref><ref id="B23"><label>23</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Echeverr&#x000ed;a-Rodr&#x000ed;guez</surname><given-names>O.</given-names></name><name><surname>Del Valle-Mondrag&#x000f3;n</surname><given-names>L.</given-names></name><name><surname>Hong</surname><given-names>E.</given-names></name></person-group><article-title>Angiotensin 1-7 improves insulin sensitivity by increasing skeletal muscle glucose uptake in vivo</article-title><source><italic toggle="yes">Peptides</italic></source><year>2014</year><volume>51</volume><fpage>26</fpage><lpage>30</lpage><pub-id pub-id-type="doi">10.1016/j.peptides.2013.10.022</pub-id><pub-id pub-id-type="other">2-s2.0-84888091647</pub-id><pub-id pub-id-type="pmid">24184594</pub-id></element-citation></ref><ref id="B24"><label>24</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mu&#x000f1;oz</surname><given-names>M. C.</given-names></name><name><surname>Giani</surname><given-names>J. F.</given-names></name><name><surname>Burghi</surname><given-names>V.</given-names></name><etal/></person-group><article-title>The Mas receptor mediates modulation of insulin signaling by angiotensin-(1-7)</article-title><source><italic toggle="yes">Regulatory Peptides</italic></source><year>2012</year><volume>177</volume><issue>1-3</issue><fpage>1</fpage><lpage>11</lpage><pub-id pub-id-type="doi">10.1016/j.regpep.2012.04.001</pub-id><pub-id pub-id-type="other">2-s2.0-84862757033</pub-id><pub-id pub-id-type="pmid">22561450</pub-id></element-citation></ref><ref id="B25"><label>25</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Marcus</surname><given-names>Y.</given-names></name><name><surname>Shefer</surname><given-names>G.</given-names></name><name><surname>Sasson</surname><given-names>K.</given-names></name><etal/></person-group><article-title>Angiotensin 1-7 as means to prevent the metabolic syndrome: lessons from the fructose-fed rat model</article-title><source><italic toggle="yes">Diabetes</italic></source><year>2013</year><volume>62</volume><issue>4</issue><fpage>1121</fpage><lpage>1130</lpage><pub-id pub-id-type="doi">10.2337/db12-0792</pub-id><pub-id pub-id-type="other">2-s2.0-84875442204</pub-id><pub-id pub-id-type="pmid">23250359</pub-id></element-citation></ref><ref id="B26"><label>26</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wei</surname><given-names>Y.</given-names></name><name><surname>Sowers</surname><given-names>J. R.</given-names></name><name><surname>Nistala</surname><given-names>R.</given-names></name><etal/></person-group><article-title>Angiotensin II-induced NADPH oxidase activation impairs insulin signaling in skeletal muscle cells</article-title><source><italic toggle="yes">The Journal of Biological Chemistry</italic></source><year>2006</year><volume>281</volume><issue>46</issue><fpage>35137</fpage><lpage>35146</lpage><pub-id pub-id-type="doi">10.1074/jbc.M601320200</pub-id><pub-id pub-id-type="other">2-s2.0-33845932608</pub-id><pub-id pub-id-type="pmid">16982630</pub-id></element-citation></ref><ref id="B27"><label>27</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bloch-Damti</surname><given-names>A.</given-names></name><name><surname>Bashan</surname><given-names>N.</given-names></name></person-group><article-title>Proposed mechanisms for the induction of insulin resistance by oxidative stress</article-title><source><italic toggle="yes">Antioxidants &#x00026; Redox Signaling</italic></source><year>2005</year><volume>7</volume><issue>11-12</issue><fpage>1553</fpage><lpage>1567</lpage><pub-id pub-id-type="doi">10.1089/ars.2005.7.1553</pub-id><pub-id pub-id-type="other">2-s2.0-28844461131</pub-id><pub-id pub-id-type="pmid">16356119</pub-id></element-citation></ref><ref id="B28"><label>28</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Verano-Braga</surname><given-names>T.</given-names></name><name><surname>Schw&#x000e4;mmle</surname><given-names>V.</given-names></name><name><surname>Sylvester</surname><given-names>M.</given-names></name><etal/></person-group><article-title>Time-resolved quantitative phosphoproteomics: new insights into angiotensin-(1-7) signaling networks in human endothelial cells</article-title><source><italic toggle="yes">Journal of Proteome Research</italic></source><year>2012</year><volume>11</volume><issue>6</issue><fpage>3370</fpage><lpage>3381</lpage><pub-id pub-id-type="doi">10.1021/pr3001755</pub-id><pub-id pub-id-type="other">2-s2.0-84861832045</pub-id><pub-id pub-id-type="pmid">22497526</pub-id></element-citation></ref><ref id="B29"><label>29</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Falasca</surname><given-names>M.</given-names></name><name><surname>Hughes</surname><given-names>W. E.</given-names></name><name><surname>Dominguez</surname><given-names>V.</given-names></name><etal/></person-group><article-title>The role of phosphoinositide 3-kinase C2<italic>&#x003b1;</italic> in insulin signaling</article-title><source><italic toggle="yes">The Journal of Biological Chemistry</italic></source><year>2007</year><volume>282</volume><issue>38</issue><fpage>28226</fpage><lpage>28236</lpage><pub-id pub-id-type="doi">10.1074/jbc.M704357200</pub-id><pub-id pub-id-type="other">2-s2.0-34948866354</pub-id><pub-id pub-id-type="pmid">17644513</pub-id></element-citation></ref><ref id="B30"><label>30</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Williams</surname><given-names>I. M.</given-names></name><name><surname>Otero</surname><given-names>Y. F.</given-names></name><name><surname>Bracy</surname><given-names>D. P.</given-names></name><name><surname>Wasserman</surname><given-names>D. H.</given-names></name><name><surname>Biaggioni</surname><given-names>I.</given-names></name><name><surname>Arnold</surname><given-names>A. C.</given-names></name></person-group><article-title>Chronic angiotensin-(1-7) improves insulin sensitivity in high-fat fed mice independent of blood pressure</article-title><source><italic toggle="yes">Hypertension</italic></source><year>2016</year><volume>67</volume><issue>5</issue><fpage>983</fpage><lpage>991</lpage><pub-id pub-id-type="doi">10.1161/HYPERTENSIONAHA.115.06935</pub-id><pub-id pub-id-type="other">2-s2.0-84961231074</pub-id><pub-id pub-id-type="pmid">26975707</pub-id></element-citation></ref></ref-list></back><floats-group><fig id="fig1" orientation="portrait" position="float"><label>Figure 1</label><caption><p>Levels of TBARS (U/mL/mg of protein) (a, b), activity of the catalase enzyme (CAT, U/mg of protein) (c, d), and activity of the enzyme superoxide dismutase (SOD, U/mg of protein) (e, f) in the liver and gastrocnemius muscle of rats subjected to a high-fat diet (37% fat, FAT; <italic>n</italic> = 6) or control diet (AIN-93, CT; <italic>n</italic> = 7) for 13 weeks and treated with vehicle (HP<italic>&#x003b2;</italic>CD) or HP<italic>&#x003b2;</italic>CD-Ang-(1-7) during the last 6 weeks of diets. <sup>&#x02217;</sup><italic>p</italic> &#x0003c; 0.05 compared to the CT-HP<italic>&#x003b2;</italic>CD/empty group. <sup>#</sup><italic>p</italic> &#x0003c; 0.05 compared to the group FAT-HP<italic>&#x003b2;</italic>CD/empty (two-way ANOVA followed by Fisher's LSD posttest).</p></caption><graphic xlink:href="OMCL2019-5868935.001"/></fig><fig id="fig2" orientation="portrait" position="float"><label>Figure 2</label><caption><p>Evaluation of the mRNA expression components of the RAS <italic>angiotensin</italic> (a), angiotensin-converting enzyme (<italic>ACE</italic>) (b), angiotensin II receptor type 1 (<italic>AT1R</italic>) (c), angiotensin-converting enzyme 2 (<italic>ACE2</italic>) (d), and receptor mass (<italic>Masr</italic>) (e) in the liver of rats subjected to a high-fat diet (37% fat, FAT; <italic>n</italic> = 6) or control diet (AIN-93, CT; <italic>n</italic> = 7) for 13 weeks and treated with vehicle (HP<italic>&#x003b2;</italic>CD) or HP<italic>&#x003b2;</italic>CD-Ang-(1-7) during the last 6 weeks of diets. <sup>&#x02217;</sup><italic>p</italic> &#x0003c; 0.05 compared to the CT-HP<italic>&#x003b2;</italic>CD/empty group. <sup>#</sup><italic>p</italic> &#x0003c; 0.05 compared to the group FAT-HP<italic>&#x003b2;</italic>CD/empty (two-way ANOVA followed by Fisher's LSD posttest).</p></caption><graphic xlink:href="OMCL2019-5868935.002"/></fig><fig id="fig3" orientation="portrait" position="float"><label>Figure 3</label><caption><p>Evaluation of the mRNA expression of insulin signaling pathway mediators. Insulin receptor substrate 1 (<italic>Irs-1</italic>) (a, b), protein kinase B (<italic>Akt-2</italic>) (c, d), and type glucose transporter 4 (<italic>Glut-4</italic>) (e, f) in the liver and gastrocnemius muscle of rats subjected to a high-fat diet (37% fat, FAT; <italic>n</italic> = 6) or control diet (AIN-93, CT; <italic>n</italic> = 7) for 13 weeks and treated with vehicle (HP<italic>&#x003b2;</italic>CD) or HP<italic>&#x003b2;</italic>CD-Ang-(1-7) during the last 6 weeks of diets. <sup>&#x02217;</sup><italic>p</italic> &#x0003c; 0.05 compared to the CT-HP<italic>&#x003b2;</italic>CD/empty group. <sup>#</sup><italic>p</italic> &#x0003c; 0.05 compared to the FAT-HP<italic>&#x003b2;</italic>CD/empty group (two-way ANOVA followed by Fisher's LSD posttest).</p></caption><graphic xlink:href="OMCL2019-5868935.003"/></fig><fig id="fig4" orientation="portrait" position="float"><label>Figure 4</label><caption><p>Photomicrographs of the liver stained with hematoxylin and eosin (HE). The arrow indicates microvesicular steatosis, and the arrowhead indicates macrovesicular steatosis. (a) Rats fed with control (CT) diet and treated only with the vehicle (HP<italic>&#x003b2;</italic>CD/empty). (b) Rats fed with CT diet and treated with HP<italic>&#x003b2;</italic>CD-Ang-(1-7). (c) Rats fed with high-fat (FAT) diet and treated with HP<italic>&#x003b2;</italic>CD/empty. (d) Rats fed with FAT diet and treated with HP<italic>&#x003b2;</italic>CD-Ang-(1-7). Magnification &#x000d7;440. Bar = 50&#x000a0;<italic>&#x003bc;</italic>m. Qualitative evaluation of macrovesicular steatosis (e) and microvesicular steatosis (f) in the hepatic tissue, using the degrees of Absent, Mild, Moderate, or Intense.</p></caption><graphic xlink:href="OMCL2019-5868935.004"/></fig><table-wrap id="tab1" orientation="portrait" position="float"><label>Table 1</label><caption><p>Evaluation of MetS establishment in rats after 7 weeks of FAT diet.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="1" colspan="1">Parameters</th><th align="center" rowspan="1" colspan="1">CT-HP<italic>&#x003b2;</italic>CD/empty</th><th align="center" rowspan="1" colspan="1">FAT-HP<italic>&#x003b2;</italic>CD/empty</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Body mass (g)</td><td align="center" rowspan="1" colspan="1">168 &#x000b1; 6.7</td><td align="center" rowspan="1" colspan="1">275 &#x000b1; 9.1<sup>&#x02217;</sup></td></tr><tr><td align="left" rowspan="1" colspan="1">Blood glucose level (mg/dL)</td><td align="center" rowspan="1" colspan="1">101 &#x000b1; 1.6</td><td align="center" rowspan="1" colspan="1">127 &#x000b1; 2.5<sup>&#x02217;</sup></td></tr><tr><td align="left" rowspan="1" colspan="1">MAP (mmHg)</td><td align="center" rowspan="1" colspan="1">106 &#x000b1; 4.5</td><td align="center" rowspan="1" colspan="1">136 &#x000b1; 2.0<sup>&#x02217;</sup></td></tr><tr><td align="left" rowspan="1" colspan="1">HR (bpm)</td><td align="center" rowspan="1" colspan="1">368 &#x000b1; 6.3</td><td align="center" rowspan="1" colspan="1">433 &#x000b1; 6.3<sup>&#x02217;</sup></td></tr><tr><td align="left" rowspan="1" colspan="1">
<italic>N</italic>
</td><td align="center" rowspan="1" colspan="1">6-14</td><td align="center" rowspan="1" colspan="1">6-14</td></tr></tbody></table><table-wrap-foot><fn><p>
<sup>&#x02217;</sup>
<italic>p</italic> &#x0003c; 0.05 compared to CT-HP<italic>&#x003b2;</italic>CD/empty group. Values are expressed as mean&#x02009;values &#x000b1; standard&#x02009;error of the mean and analyzed using unpaired student <italic>t-</italic>test. MAP&#x02009;=&#x02009;mean arterial pressure; HR&#x02009;=&#x02009;heart rate; <italic>N</italic>&#x02009;=&#x02009;number of animals.</p></fn></table-wrap-foot></table-wrap><table-wrap id="tab2" orientation="portrait" position="float"><label>Table 2</label><caption><p>Nutritional, biometric, and biochemical parameters of rats fed with a control diet or high-fat diet for 13 weeks and treated with HP<italic>&#x003b2;</italic>CD or HP<italic>&#x003b2;</italic>CD/Ang-(1-7) during the last 6 weeks of the diet.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="3" colspan="1">Parameters</th><th align="center" colspan="4" rowspan="1">Experimental groups</th></tr><tr><th align="center" colspan="2" rowspan="1">CT diet</th><th align="center" colspan="2" rowspan="1">FAT diet</th></tr><tr><th align="center" rowspan="1" colspan="1">HP<italic>&#x003b2;</italic>CD</th><th align="center" rowspan="1" colspan="1">HP<italic>&#x003b2;</italic>CD/Ang-(1-7)</th><th align="center" rowspan="1" colspan="1">HP<italic>&#x003b2;</italic>CD</th><th align="center" rowspan="1" colspan="1">HP<italic>&#x003b2;</italic>CD/Ang-(1-7)</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Food intake (g)</td><td align="center" rowspan="1" colspan="1">87.5 &#x000b1; 5.3</td><td align="center" rowspan="1" colspan="1">84.4 &#x000b1; 1.5</td><td align="center" rowspan="1" colspan="1">72.5 &#x000b1; 3.9<sup>&#x02217;</sup></td><td align="center" rowspan="1" colspan="1">72.3 &#x000b1; 1.2<sup>&#x02217;</sup></td></tr><tr><td align="left" rowspan="1" colspan="1">Caloric intake (kcal)</td><td align="center" rowspan="1" colspan="1">332.4 &#x000b1; 20.2</td><td align="center" rowspan="1" colspan="1">320.8 &#x000b1; 5.5</td><td align="center" rowspan="1" colspan="1">377.2 &#x000b1; 20.6</td><td align="center" rowspan="1" colspan="1">376.2 &#x000b1; 6.5</td></tr><tr><td align="left" rowspan="1" colspan="1">Liver (g/100&#x02009;g rat mass)</td><td align="center" rowspan="1" colspan="1">2.73 &#x000b1; 0.04</td><td align="center" rowspan="1" colspan="1">2.71 &#x000b1; 0.07</td><td align="center" rowspan="1" colspan="1">2.8 &#x000b1; 0.11</td><td align="center" rowspan="1" colspan="1">2.57 &#x000b1; 0.04</td></tr><tr><td align="left" rowspan="1" colspan="1">Gastrocnemius (g/100&#x02009;g rat mass)</td><td align="center" rowspan="1" colspan="1">1.31 &#x000b1; 0.03</td><td align="center" rowspan="1" colspan="1">1.28 &#x000b1; 0.03</td><td align="center" rowspan="1" colspan="1">1.15 &#x000b1; 0.08</td><td align="center" rowspan="1" colspan="1">1.24 &#x000b1; 0.02</td></tr><tr><td align="left" rowspan="1" colspan="1">Adiposity index</td><td align="center" rowspan="1" colspan="1">6.7 &#x000b1; 0.4</td><td align="center" rowspan="1" colspan="1">5.3 &#x000b1; 0.4</td><td align="center" rowspan="1" colspan="1">10.7 &#x000b1; 0.2<sup>&#x02217;</sup></td><td align="center" rowspan="1" colspan="1">8.2 &#x000b1; 0.6<sup>#</sup></td></tr><tr><td align="left" rowspan="1" colspan="1">Body mass (g)</td><td align="center" rowspan="1" colspan="1">282.7 &#x000b1; 2.2</td><td align="center" rowspan="1" colspan="1">273.9 &#x000b1; 13.9</td><td align="center" rowspan="1" colspan="1">348.7 &#x000b1; 9.4<sup>&#x02217;</sup></td><td align="center" rowspan="1" colspan="1">259.6 &#x000b1; 9.1<sup>#</sup></td></tr><tr><td align="left" rowspan="1" colspan="1">Fasting glucose (mg/dL)</td><td align="center" rowspan="1" colspan="1">111 &#x000b1; 1.4</td><td align="center" rowspan="1" colspan="1">113 &#x000b1; 1.95</td><td align="center" rowspan="1" colspan="1">123.1 &#x000b1; 1.7<sup>&#x02217;</sup></td><td align="center" rowspan="1" colspan="1">117.4 &#x000b1; 1.9</td></tr><tr><td align="left" rowspan="1" colspan="1">Total cholesterol (mg/dL)</td><td align="center" rowspan="1" colspan="1">65.6 &#x000b1; 1.6</td><td align="center" rowspan="1" colspan="1">64.4 &#x000b1; 1.3</td><td align="center" rowspan="1" colspan="1">75.1 &#x000b1; 2.5<sup>&#x02217;</sup></td><td align="center" rowspan="1" colspan="1">70.3 &#x000b1; 1.9</td></tr><tr><td align="left" rowspan="1" colspan="1">LDL cholesterol (mg/dL)</td><td align="center" rowspan="1" colspan="1">9.4 &#x000b1; 2.0</td><td align="center" rowspan="1" colspan="1">10.2 &#x000b1; 1.4</td><td align="center" rowspan="1" colspan="1">27.3 &#x000b1; 3.3<sup>&#x02217;</sup></td><td align="center" rowspan="1" colspan="1">26.5 &#x000b1; 3.3<sup>#</sup></td></tr><tr><td align="left" rowspan="1" colspan="1">HDL cholesterol (mg/dL)</td><td align="center" rowspan="1" colspan="1">30.5 &#x000b1; 0.9</td><td align="center" rowspan="1" colspan="1">29.12 &#x000b1; 0.6</td><td align="center" rowspan="1" colspan="1">28.4 &#x000b1; 1.3</td><td align="center" rowspan="1" colspan="1">29.8 &#x000b1; 1.1</td></tr><tr><td align="left" rowspan="1" colspan="1">Triglycerides (mg/dL)</td><td align="center" rowspan="1" colspan="1">42.1 &#x000b1; 3.5</td><td align="center" rowspan="1" colspan="1">38.9 &#x000b1; 3.6</td><td align="center" rowspan="1" colspan="1">68.2 &#x000b1; 5.9<sup>&#x02217;</sup></td><td align="center" rowspan="1" colspan="1">40.7 &#x000b1; 4.5<sup>#</sup></td></tr><tr><td align="left" rowspan="1" colspan="1">ALT (U/L)</td><td align="center" rowspan="1" colspan="1">52.7 &#x000b1; 0.8</td><td align="center" rowspan="1" colspan="1">52.1 &#x000b1; 8.6</td><td align="center" rowspan="1" colspan="1">70.9 &#x000b1; 2.1<sup>&#x02217;</sup></td><td align="center" rowspan="1" colspan="1">60.7 &#x000b1; 1.9</td></tr><tr><td align="left" rowspan="1" colspan="1">AST (U/L)</td><td align="center" rowspan="1" colspan="1">3.5 &#x000b1; 0.8</td><td align="center" rowspan="1" colspan="1">2.7 &#x000b1; 0.2</td><td align="center" rowspan="1" colspan="1">2.9 &#x000b1; 0.6</td><td align="center" rowspan="1" colspan="1">3.2 &#x000b1; 1.4</td></tr><tr><td align="left" rowspan="1" colspan="1">
<italic>N</italic>
</td><td align="center" rowspan="1" colspan="1">7</td><td align="center" rowspan="1" colspan="1">7</td><td align="center" rowspan="1" colspan="1">7</td><td align="center" rowspan="1" colspan="1">7</td></tr></tbody></table><table-wrap-foot><fn><p>
<sup>&#x02217;</sup>
<italic>p</italic> &#x0003c; 0.05 compared to CT-HP<italic>&#x003b2;</italic>CD/empty group; <sup>#</sup><italic>p</italic> &#x0003c; 0.05 compared to HF-HP<italic>&#x003b2;</italic>CD/empty group (two-way ANOVA followed by Bonferroni test), expressed as mean&#x02009;values &#x000b1; standard&#x02009;error of the mean. <italic>N</italic>&#x02009;=&#x02009;number of animals.</p></fn></table-wrap-foot></table-wrap></floats-group></article>